Literature DB >> 27882125

Protective effect of higenamine ameliorates collagen-induced arthritis through heme oxygenase-1 and PI3K/Akt/Nrf-2 signaling pathways.

Wenjiang Duan1, Jianmin Chen1, Yu Wu1, Yong Zhang1, Yuansheng Xu1.   

Abstract

Existing in Ranunculaceae Aconitum and tomato, with the chemical name 1-phydroxybenzyl-1,2,3,4-tetrahy-droisoquinoline, higenamine is widely distributed in China. Higenamine's anti-inflammatory, antioxidant and anti-apoptotic effects have been identified in previous studies. The present study attempted to determine the protective effect of higenamine against collagen-induced arthritis through heme oxygenase-1 (HO-1) and PI3K/Akt/Nrf-2 signaling pathways. A type II collagen (CII)-induced arthritis (CIA) model was established and clinical arthritis scores were used to appraise the curative effect of higenamine. Inflammatory reactions, oxidative damage and caspase-3/9 activation were detected using specific ELISA kits. In addition, western blotting was used to evaluate the expression of HO-1, Akt and Nrf-2 protein in CII-induced CIA mice. In CII-induced CIA mice, the clinical arthritis scores, inflammatory reactions, oxidation damage and caspase-3/9 activation were increased and activated. The results demonstrated that treatment with higenamine significantly reduced the elevation of clinical arthritis scores (P<0.01), and suppressed the promotion of inflammatory reactions, oxidation damage and caspase-3/9 activation. Furthermore, higenamine significantly increased HO-1 protein expression (P<0.01) and upregulated the PI3K/Akt/Nrf-2 signal pathway in CII-induced CIA mice. Collectively, it is concluded that higenamine protects against CII-induced CIA through the induction of HO-1 and the upregulation of the PI3K/Akt/Nrf-2 signaling pathway. In conclusion, higenamine may be a beneficial drug for protecting against CIA.

Entities:  

Keywords:  heme oxygenase-1; higenamine; phosphatidylinositol-3-kinase/protein kinase B/nuclear factor (erythroid-derived 2)-like 2; type I collagen-induced arthritis

Year:  2016        PMID: 27882125      PMCID: PMC5103755          DOI: 10.3892/etm.2016.3730

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  Additive triple DMARD combination therapy of a low dose of sulfhydryl compounds, sulfasalazine and methotrexate in the treatment of rheumatoid arthritis: a clinical trial.

Authors:  K Nishiya; N Hisakawa; K Tahara; A Matsumori; H Ito; K Hashimoto; K Nakatani; K Takatori
Journal:  Acta Med Okayama       Date:  1999-12       Impact factor: 0.892

2.  Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats.

Authors:  H Kamada; M Goto; S Matsuura; Y Takaoka; H Nagai
Journal:  Jpn J Pharmacol       Date:  1997-08

3.  Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways.

Authors:  Yu Mi Ha; Min Young Kim; Min Kyu Park; Young Soo Lee; Young Min Kim; Hye Jung Kim; Jae Heun Lee; Ki Churl Chang
Journal:  Apoptosis       Date:  2012-05       Impact factor: 4.677

4.  Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.

Authors:  A Kavanaugh; E W St Clair; W J McCune; T Braakman; P Lipsky
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

5.  (1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis.

Authors:  Zhigang Wang; Zhe Chen; Sisi Yang; Yu Wang; Lifang Yu; Bicheng Zhang; Zhiguo Rao; Jianfei Gao; Shenghao Tu
Journal:  Exp Ther Med       Date:  2012-05-03       Impact factor: 2.447

6.  Effect of Xinfeng capsule on nuclear factor Kappa B/tumor necrosis factor alpha and transforming growth factor beta 1/Smads pathways in rats with cardiac injuries induced by adjuvant arthritis.

Authors:  Chuanbing Huang; Lei Wan; Jian Liu
Journal:  J Tradit Chin Med       Date:  2016-02       Impact factor: 0.848

7.  A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects.

Authors:  Sheng Feng; Ji Jiang; Pei Hu; Jian-yan Zhang; Tao Liu; Qian Zhao; Bi-lu Li
Journal:  Acta Pharmacol Sin       Date:  2012-10-22       Impact factor: 6.150

8.  Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis.

Authors:  Tej K Pareek; Abdelmadjid Belkadi; Sashi Kesavapany; Anita Zaremba; Sook L Loh; Lianhua Bai; Mark L Cohen; Colin Meyer; Karen T Liby; Robert H Miller; Michael B Sporn; John J Letterio
Journal:  Sci Rep       Date:  2011-12-19       Impact factor: 4.379

9.  Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis.

Authors:  Rene Westhovens; Manuel Robles; Antonio Carlos Ximenes; Jurgen Wollenhaupt; Patrick Durez; Juan Gomez-Reino; Walter Grassi; Boulos Haraoui; William Shergy; Sung-Hwan Park; Harry Genant; Charles Peterfy; Jean-Claude Becker; Bindu Murthy
Journal:  Ann Rheum Dis       Date:  2014-12-30       Impact factor: 19.103

Review 10.  Norcoclaurine synthase: mechanism of an enantioselective pictet-spengler catalyzing enzyme.

Authors:  Alessandra Bonamore; Marco Barba; Bruno Botta; Alberto Boffi; Alberto Macone
Journal:  Molecules       Date:  2010-03-24       Impact factor: 4.411

View more
  4 in total

1.  Suppressive effects of processed aconite root on dexamethasone-induced muscle ring finger protein-1 expression and its active ingredients.

Authors:  Taishi Kondo; Tomoaki Ishida; Ke Ye; Marin Muraguchi; Yohei Tanimura; Masato Yoshida; Kan'ichiro Ishiuchi; Tomoki Abe; Takeshi Nikawa; Keisuke Hagihara; Hidetoshi Hayashi; Toshiaki Makino
Journal:  J Nat Med       Date:  2022-02-18       Impact factor: 2.343

2.  Effects of the Higenamine, a Potent Compound from Aconitum, on UVB-Induced Photoaging in Hairless Mice.

Authors:  Hye-Sun Lim; Yumi Jang; Gunhyuk Park
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-27       Impact factor: 2.650

Review 3.  Pharmacological effects of higenamine based on signalling pathways and mechanism of action.

Authors:  De-Ta Chen; Wu Rao; Xue Shen; Lin Chen; Zi-Jian Wan; Xiao-Ping Sheng; Tian-You Fan
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

4.  Synthesis and Detailed Examination of Spectral Properties of (S) and (R)-Higenamine 4'-O-β-d-Glucoside and HPLC Analytical Conditions to Distinguish the Diastereomers.

Authors:  Eisuke Kato; Ryohei Iwata; Jun Kawabata
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.